Regulating Acidosis and Relieving Hypoxia by Platelet Membrane-Coated Nanoparticle for Enhancing Tumor Chemotherapy.
Regulating Acidosis and Relieving Hypoxia by Platelet Membrane-Coated Nanoparticle for Enhancing Tumor Chemotherapy.
复制标题
DOI:
10.3389/fbioe.2022.885105
复制
发表时间:
2022
影响因子:
5.7
通讯作者:
Hu, Yong
中科院分区:
文献类型:
--
作者:
Luo, Xingyu;Cao, Jian;Yu, Jianming;Dai, Dongqing;Jiang, Wei;Feng, Yahui;Hu, Yong
Acidosis and hypoxia of tumor remain a great challenge for cancer therapy. Herein, we developed Hb-LOX-DOX-ZIF8@platelet membrane nanoparticles (H-L-D-Z@PM NPs) to address this problem. Lactate oxidase (LOX) could deplete intratumoral lactate adequately and amplify oxidative stress efficiently. In the meantime, hemoglobin (Hb) was intended to deliver oxygen, relieve hypoxia, and boost the catalytic activity of LOX. The coated PM bestowed active tumor-targeting ability and good biocompatibility to these nanoparticles. Moreover, the encapsulation of zeolitic imidazolate framework-8 (ZIF8) offered the acid response capacity to nanoparticles. With the synergism of chemotherapy drug doxorubicin (DOX), these H-L-D-Z@PM NPs appeared to have excellent antitumor competence. Collectively, this study offered a new strategy for enhancing tumor chemotherapy by regulating acidosis and relieving hypoxia.
登录
查看更多内容
影响因子:
15.1
作者:
Liu, Junjie;Jin, Yajie;Shi, Jinjin
通讯作者:
Shi, Jinjin
影响因子:
3.7
作者:
Otsuka Y;Kiyohara C;Kashiwado Y;Sawabe T;Nagano S;Kimoto Y;Ayano M;Mitoma H;Akahoshi M;Arinobu Y;Niiro H;Akashi K;Horiuchi T
通讯作者:
Horiuchi T
影响因子:
13.3
作者:
Zhang, Liming;Xia, Jingguang;Zhang, Zhijun
通讯作者:
Zhang, Zhijun
影响因子:
4.6
作者:
Liu, Sen;Luo, Xingyu;Hu, Yong
通讯作者:
Hu, Yong
影响因子:
82.9
作者:
Binnewies M;Roberts EW;Kersten K;Chan V;Fearon DF;Merad M;Coussens LM;Gabrilovich DI;Ostrand-Rosenberg S;Hedrick CC;Vonderheide RH;Pittet MJ;Jain RK;Zou W;Howcroft TK;Woodhouse EC;Weinberg RA;Krummel MF
通讯作者:
Krummel MF